LifeStance Health Group, Inc. LFST
11.84
0.04
0.34%
as of 25 Sep
- Market cap
- $4.5B
- P/E
- 89.0×
Follow LFST
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(0.62%) | 0.65% | 1.58% | 3.43% | |
| (0.43%) | 0.45% | 1.09% | 2.34% | ||
ROIC |
0.29% | 0.98% | 1.81% | 3.25% | |
Return on Tangible Assets |
(3.10%) | 2.97% | 8.35% | 18.89% | |
Average Days of Receivables |
32.31 | 24.53 | 30.01 | 25.56 | |
Free Cash Flow per Share |
0.31 | 0.29 | 0.37 | 0.45 | |
Free Cash Flow |
119.39 | 110.03 | 142.63 | 173.91 | |
Capital Expenditures |
(31.51) | (36.12) | (39.72) | (43.96) | |
Piotroski F-Score |
7.00 | 8.00 | 8.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
7.68% | 7.18% | 9.43% | 11.10% | |
Accounts Receivable Turnover |
9.80 | 12.52 | 11.35 | 13.18 | |
Accounts Payable Turnover |
94.72 | 144.15 | 172.13 | 111.75 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
4.83 | 2.32 | 1.55 | 3.83 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.22) | (0.22) | (0.31) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.87% | 26.83% | 25.96% | 25.17% | |
Share Based Compensation of Revenue |
5.42% | 5.24% | 4.77% | 4.41% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(16.55) | 15.12 | 7.86 | 4.31 | |
Depreciation/Fixed assets |
0.35 | 0.35 | 0.34 | 0.34 | |
Capex/Depreciation |
(0.55) | (0.65) | (0.72) | (0.79) | |
Revenue per Share |
3.53 | 3.69 | 3.86 | 4.13 | |
Operating CF per Share |
0.39 | 0.38 | 0.47 | 0.57 | |
Capex per Share |
(0.08) | (0.09) | (0.10) | (0.11) | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
(0.67%) | 0.68% | 1.55% | 3.19% |
Columns are period end dates